Skip to content

BillionToOne vs EMPE Diagnostics

BillionToOne logo

BillionToOne

We push the boundaries of molecular diagnostics through quantitative technologies

815 employees · est. 2016 · Menlo Park, United States

VS
EMPE Diagnostics logo

EMPE Diagnostics

Confirmatory precision diagnostics for tuberculosis (MDR/XDR-TB) within 3 h even at resource-limited labs

27 employees · est. 2015 · Solna, Sweden

EMPE Diagnostics is the older company (2016 vs 2015); BillionToOne is the larger of the two.

Side-by-Side Comparison

BillionToOne EMPE Diagnostics
Founded
2016 2015 older
Headquarters
Menlo Park, United States Solna, Sweden
Employees
815 larger 27
Industry
Biotechnology, Health Care Biotechnology, Health Care, Medical Devices
Funding Stage
IPO Series A
Total Funding
$650.63M $42.94M
Funding Rounds
9 3
Services
Development and provision of advanced diagnostic tests, Quantification of disease-causing DNA fragments, Non-invasive prenatal and oncology testing solutions, Monitoring treatment response in cancer patients Not tracked yet
Target Customers
Healthcare Providers, Pregnant Women, Oncologists, Medical Researchers Not tracked yet
Taxonomy
Molecular DiagnosticsPrecision DiagnosticsDNA QuantificationMolecular Counting TechnologyDisease DetectionPrenatal Testing +7 Diagnostic TechnologyTuberculosisDrug-Resistant TBInfectious DiseaseHealthcare InnovationMedical Research +6
Website
billiontoone.com empediagnostics.com
BillionToOne logo

About BillionToOne

BillionToOne, founded in 2016, is a pioneering entity in the Biotechnology and Health Care industries, headquartered in the United States. The company is renowned for its commitment to enhancing the accuracy, efficiency, and accessibility of molecular diagnostics, encapsulated in their slogan: "We p...

EMPE Diagnostics logo

About EMPE Diagnostics

Empe Diagnostics is a Swedish biotech company founded in 2015 that focuses on precision diagnostics for tuberculosis (MDR/XDR-TB) with the slogan "Confirmatory precision diagnostics for tuberculosis (MDR/XDR-TB) within 3 h even at resource-limited labs." With 10 million new cases of Tuberculosis (TB...

Also comparing in this category

Comparing more than these two?

Get BillionToOne, EMPE Diagnostics and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does BillionToOne compare?

A PDF of BillionToOne and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

BillionToOne was founded in 2016, based in Menlo Park, United States, with 815 employees. BillionToOne, founded in 2016, is a pioneering entity in the Biotechnology and Health Care industries, headquartered in the United States. The company is renowned for its commitment to enhancing the a. EMPE Diagnostics was founded in 2015, based in Solna, Sweden, with 27 employees. Empe Diagnostics is a Swedish biotech company founded in 2015 that focuses on precision diagnostics for tuberculosis (MDR/XDR-TB) with the slogan "Confirmatory precision diagnostics for tuberculosis (.
BillionToOne has raised $650.63M and EMPE Diagnostics $42.94M. Latest stage: BillionToOne IPO, EMPE Diagnostics Series A.
Both work in Biotechnology and Health Care and list molecular diagnostics among their focus areas.

Compare BillionToOne with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at BillionToOne on 9 Jun 2026, and EMPE Diagnostics on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout